CATX
Perspective Therapeutics, Inc.
Key Financials
Net Income
$-103121000
↓ 30.1%
Gross Profit
$1.4M
↑ Infinity%
Revenue
$2.5M
↓ 13.9%
Operating Income
$-113564000
↓ 25.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
| 10-Q | 8/10/2026 | View on SEC |
| 8-K | 8/10/2026 | View on SEC |
| SCHEDULE 13G | 8/7/2026 | View on SEC |
| 8-K | 8/3/2026 | View on SEC |
| SCHEDULE 13G | 7/29/2026 | View on SEC |
| SCHEDULE 13G | 7/20/2026 | View on SEC |
| 8-K | 7/1/2026 | View on SEC |
| SCHEDULE 13G | 6/30/2026 | View on SEC |
| 8-K | 6/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CATX |
| Company Name | Perspective Therapeutics, Inc. |
| CIK | 728387 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 206-676-0900 |